CCL3 (MIP-1a) plasma levels and the risk for disease progression in chronic lymphocytic leukemia.

CCL3 (MIP-1a) plasma levels and the risk for disease progression in chronic lymphocytic leukemia. Blood. 2011 Feb 03; 117(5):1662-9.

View in: PubMed